Company profile for REVIMMUNE INC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RevImmune is a privately held biotech company based in France, the U.S. and the U.K. RevImmune is in multiple Phase II trials with CYT107 for treatment of sepsis, certain infectious diseases and certain cancers. Over 440 patients have been treated with CYT107 in RevImmune's prior trials for multiple different viral diseases and sepsis. CYT107 showed an excellent safety profile and encouraging results in those trials.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
324 South Hyde Park Avenue Suite 350 Tampa, FL 33606 United States
Telephone
Telephone
Client Website
Website
--
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

BePharma

Not Confirmed

envelop Contact Supplier

BePharma

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/in/news-releases/revimmune-announces-phase-ii-trial-of-the-t-cell-growth-factor-cyt107-for-covid-19-823203358.html

PRNEWSWIRE
29 Jun 2020

ABOUT THIS PAGE

Contact REVIMMUNE INC and get a quotation

REVIMMUNE INC is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of CYT107 bulk offered by REVIMMUNE INC

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty